Loading...
XJPX
3154
Market cap107mUSD
Oct 09, Last price  
767.00JPY
1D
0.52%
1Q
-3.03%
Jan 2017
40.39%
IPO
458.96%
Name

Medius Holdings Co Ltd

Chart & performance

D1W1MN
XJPX:3154 chart
P/E
18.07
P/S
0.06
EPS
42.46
Div yield, %
2.62%
Shrs. gr., 5y
0.30%
Rev. gr., 5y
4.14%
Revenues
302.34b
+4.73%
58,599,294,000120,395,068,000132,833,577,000134,010,543,000145,969,388,000146,168,943,000158,400,395,000162,654,100,000168,135,875,000197,691,482,000210,388,116,000246,787,302,000221,694,333,000239,054,420,000259,789,000,000288,689,338,000302,336,775,000
Net income
944m
-31.36%
456,522,000245,358,000447,421,000896,227,000968,569,000433,295,000899,912,000863,221,000741,715,000-70,096,000951,357,0002,065,996,0001,867,916,0001,498,008,0001,124,676,0001,375,426,000944,092,000
CFO
374m
-94.66%
651,982,000-985,603,0003,889,918,000576,065,0003,045,200,000-962,560,0002,628,060,0002,447,772,000722,998,000-1,084,620,0001,169,117,0006,848,544,000-3,899,003,0001,224,486,0001,921,509,0007,011,529,000374,233,000
Dividend
Jun 29, 202620 JPY/sh

Notes

No notes on this company yet
Write a private note on this company, for your eyes only

Profile

Medius Holdings Co., Ltd. is a Japanese enterprise deeply embedded in the healthcare sector. The company's operations involve the distribution of a diverse range of medical devices, encompassing fundamental consumables such as syringes and gauze, as well as sophisticated medical systems. In addition to sales, it offers essential repair, after-sales assistance, and maintenance services for this equipment to hospitals and various other medical institutions. Medius Holdings also engages in the provision, through sale and rental, of nursing care and welfare equipment, catering to hospitals, nursing facilities, and private individuals. Moreover, the firm supplies critical emergency response items, including specialized medical instruments for ambulances, automated external defibrillators (AEDs), and other vital emergency provisions that address significant societal needs. Founded in 2009 and based in Tokyo, Japan, the company was formerly known as Kyowa Medical Holdings, Inc. before rebranding to Medius Holdings Co., Ltd. in October 2010.

Key people

Yasuhiko Ikeya
President, Executive President, Chief Executive Officer, Representative Director · since 2023
Hiroyuki Akutagawa
Senior Managing Executive Officer, Chief Senior Director of Corporate, Director · since 2023
Shinya Sumiyoshi
Senior Managing Executive Officer, President of Subsidiary, Director · since 2022
Hisayuki Furuki
Managing Executive Officer, President of Subsidiary, Director · since 2023
Hideyuki Kono
Managing Executive Officer
Nobutada Otani
Managing Executive Officer, Senior Deputy Chief Director of Main Project Supervision Unit · since 2026
Taichi Asaga
Executive Officer. Deputy Senior Chief Director of Main Planning Supervision Unit, Chief Director of Main Business Planning Unit · since 2026
Tatsuichi Sakai
Executive Officer
Masaru Kurihara
Senior Managing Executive Officer, Chairman and President of Subsidiaries, Director · since 2021
Shuhei Miyaji
Senior Managing Executive Officer, Chief Senior Director of President, President of Subsidiary, Director · since 2023
Hiroto Takei
Director · since 2023
Mitsuo Yamaguchi
Director · since 2023
Junko Echigo
Independent Director · since 2015
Norio Funayama
Independent Director · since 2019
Masako Goto
Independent Director · since 2025
Hiroshi Kudo
Independent Director · since 2019
Kazuaki Kuwahara
Independent Director · since 2023
Natsuko Shimizu
Independent Director · since 2025
Independent Director · since 2023
Akihiko Watanabe
Independent Director · since 2023
IPO date
Jul 01, 2009
Employees
2,182
Domiciled in
JP
Incorporated in
JP

Valuation

Title
JPY in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFY
2026‑062025‑062024‑062023‑062022‑062021‑062020‑062019‑062018‑062017‑06
Income
Revenues
Cost of revenue
Unusual Expense (Income)
NOPBT
NOPBT Margin
Operating Taxes
Tax Rate
NOPAT
Net income
Dividends
Dividend yield
Proceeds from repurchase of equity
BB yield
Debt
Debt current
Long-term debt
Deferred revenue
Other long-term liabilities
Net debt
Cash flow
Cash from operating activities
CAPEX
Cash from investing activities
Cash from financing activities
FCF
Balance
Cash
Long term investments
Excess cash
Stockholders' equity
Invested Capital
ROIC
ROCE
EV
Common stock shares outstanding
Price
Market cap
EV
EBITDA
EV/EBITDA
Interest
Interest/NOPBT